据《华尔街日报》5 月 20 日报道，美国食品药品监督管理局（FDA）已批准埃隆·马斯克的 Neuralink 公司为第二名患者植入脑芯片。这一消息标志着脑机接口技术的发展迈出了重要一步。
据悉，FDA 批准了 Neuralink 针对首位受试者出现的问题提出的修复方案。这一方案的通过，显示了监管机构对 Neuralink 改进措施的认可，并为该公司未来的研究提供了积极的信号。
知情人士透露，FDA 的批准意味着 Neuralink 现在计划在 6 月份的某个时候将芯片植入第二名受试者的脑内。这一手术的成功将再次引发全球对脑机接口技术的关注和讨论。
Neuralink 公司一直致力于开发能够将人脑与电脑相连接的高科技产品。该公司希望利用这一技术帮助那些神经系统受损的患者恢复感觉和运动能力。埃隆·马斯克作为公司的创始人，对这一技术的发展寄予厚望，并相信它将为人类带来巨大的变革。
然而，脑机接口技术的应用也引发了伦理和安全性的讨论。人们对植入芯片可能带来的长期影响以及隐私保护等问题表示关切。因此，FDA 的监管和审查在这一过程中起到了至关重要的作用。
这次 FDA 的批准，不仅是对 Neuralink 公司的肯定，也是对脑机接口技术发展的重要推动。未来，随着更多受试者的参与和技术的改进，我们有理由相信脑机接口技术将为人类生活带来更加深远的影响。
英语如下：
**Headline:** Second Participant Approved for Neuralink Brain-Machine Interface Trial; Surgery Scheduled for June
**Keywords:** Neuralink, Brain-Machine Interface, Trial Participant Approval
**News Content:**
### Second Brain-Machine Interface Trial Participant Approved by Neuralink; Surgery Set for June
On May 20, the Wall Street Journal reported that the U.S. Food and Drug Administration (FDA) has approved Elon Musk’s Neuralink company to implant brain chips in the second patient. This move marks an important step forward in the development of brain-machine interface technology.
It is understood that the FDA has approved a repair plan proposed by Neuralink for the issues encountered by the first participant. The passing of this plan demonstrates the regulatory body’s recognition of Neuralink’s improvements and sends a positive signal for the company’s future research.
Insiders reveal that the FDA’s approval means that Neuralink now plans to implant the chip into the second participant’s brain sometime in June. The success of this surgery will once again draw global attention and discussion about brain-machine interface technology.
Neuralink has been dedicated to the development of high-tech products that connect the human brain with computers. The company hopes to use this technology to help patients with damaged nervous systems regain sensation and motor abilities. As the founder of the company, Elon Musk has high hopes for the development of this technology and believes it will bring about tremendous change for humanity.
However, the application of brain-machine interface technology has also sparked discussions on ethics and safety. Concerns have been raised about the long-term effects of implantation and issues related to privacy protection. Therefore, the FDA’s supervision and review play a crucial role in this process.
This FDA approval is not only a confirmation of Neuralink’s efforts but also an important boost for the development of brain-machine interface technology. With more participants involved and technological advancements, there is reason to believe that brain-machine interface technology will have an even deeper impact on human life in the future.
【来源】https://www.ithome.com/0/769/383.htm
Views: 1